Gutwerg Ori, SVP of Generics at ANI Pharmaceuticals ($ANIP), sold shares on the open market three times in the last year, totaling about $719,000. The most recent sale occurred on March 3, 2026. These sales rank 5,672nd among nearly 12,000 insiders in our database, where the average is $8.6 million across 6.4 transactions. Ori made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 7, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | F | Common Stock | 3314 | $74.04 | 81,468.0000 | 23,076,000 | 3.91% | 0.01% |
| March 3, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | S | Common Stock | 2060 | $76.50 | 84,782.0000 | 23,076,000 | 2.37% | 0.01% |
| Feb. 28, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | F | Common Stock | 2221 | $73.90 | 86,842.0000 | 23,076,000 | 2.49% | 0.01% |
| Feb. 26, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | A | Common Stock | 12969 | $77.15 | 89,063.0000 | 23,076,000 | 17.04% | 0.06% |
| Feb. 12, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | F | Common Stock | 1775 | $76.70 | 77,982.0000 | 23,076,000 | 2.23% | 0.01% |
| Feb. 14, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | F | Common Stock | 1888 | $77.36 | 76,094.0000 | 23,076,000 | 2.42% | 0.01% |
| Feb. 11, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | F | Common Stock | 4267 | $76.25 | 79,757.0000 | 23,076,000 | 5.08% | 0.02% |
| Aug. 12, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | S | Common Stock | 5873 | $86.53 | 84,024.0000 | 22,322,000 | 6.53% | 0.03% |
| May 15, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | S | Common Stock | 881 | $60.07 | 89,897.0000 | 21,538,000 | 0.97% | 0.00% |
| March 7, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | F | Common Stock | 3314 | $60.62 | 90,778.0000 | 21,538,000 | 3.52% | 0.02% |
| March 5, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | M | Common Stock | 300 | $31.49 | 99,476.0000 | 21,538,000 | 0.30% | 0.00% |
| March 5, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | S | Common Stock | 5084 | $60.00 | 94,092.0000 | 21,538,000 | 5.13% | 0.02% |
| March 5, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | M | Stock Option (right to buy) | 300 | $31.49 | 13,204.0000 | 21,538,000 | 2.22% | 0.00% |
| March 5, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | S | Common Stock | 300 | $60.03 | 99,176.0000 | 21,538,000 | 0.30% | 0.00% |
| Feb. 28, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | F | Common Stock | 1570 | $61.89 | 99,176.0000 | 21,538,000 | 1.56% | 0.01% |
| Feb. 12, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | A | Common Stock | 15668 | $0.00 | 92,895.0000 | 21,538,000 | 20.29% | 0.07% |
| Feb. 12, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | A | Common Stock | 10444 | $0.00 | 103,339.0000 | 21,538,000 | 11.24% | 0.05% |
| Feb. 14, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | F | Common Stock | 1426 | $58.92 | 101,913.0000 | 21,538,000 | 1.38% | 0.01% |
| Feb. 15, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | F | Common Stock | 1167 | $58.92 | 100,746.0000 | 21,538,000 | 1.15% | 0.01% |
| June 5, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | S | Common Stock | 2985 | $67.00 | 77,227.0000 | 20,731,000 | 3.72% | 0.01% |
| March 7, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | F | Common Stock | 2494 | $66.71 | 80,212.0000 | 20,731,000 | 3.02% | 0.01% |
| Feb. 29, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | F | Common Stock | 1570 | $67.67 | 82,706.0000 | 20,731,000 | 1.86% | 0.01% |
| Feb. 15, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | F | Common Stock | 1244 | $57.55 | 84,276.0000 | 20,731,000 | 1.45% | 0.01% |
| Feb. 14, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | A | Common Stock | 14763 | $0.00 | 75,678.0000 | 20,731,000 | 24.24% | 0.07% |
| Feb. 14, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | A | Common Stock | 9842 | $0.00 | 85,520.0000 | 20,731,000 | 13.01% | 0.05% |
| Aug. 23, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | M | Common Stock | 13502 | $31.49 | 76,476.0000 | 17,644,000 | 21.44% | 0.08% |
| Aug. 23, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | S | Common Stock | 2059 | $62.39 | 60,915.0000 | 17,644,000 | 3.27% | 0.01% |
| Aug. 23, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | M | Stock Option (right to buy) | 13502 | $31.49 | 13,504.0000 | 17,644,000 | 50.00% | 0.08% |
| Aug. 23, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | S | Common Stock | 13502 | $62.39 | 62,974.0000 | 17,644,000 | 17.66% | 0.08% |
| Feb. 28, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | A | Common Stock | 11578 | $0.00 | 62,974.0000 | 17,644,000 | 22.53% | 0.07% |
| Feb. 28, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | A | Common Stock | 17369 | $0.00 | 51,396.0000 | 17,644,000 | 51.04% | 0.10% |
| March 7, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | F | Common Stock | 586 | $44.23 | 34,027.0000 | 17,644,000 | 1.69% | 0.00% |
| March 7, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | F | Common Stock | 1756 | $44.23 | 34,613.0000 | 17,644,000 | 4.83% | 0.01% |
| Feb. 15, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Gutwerg Ori | SVP, GENERICS | F | Common Stock | 1275 | $45.04 | 36,369.0000 | 17,644,000 | 3.39% | 0.01% |